LNSR
LNSR
NASDAQ · Health Care

Lensar Inc

$12.08
-0.20 (-1.63%)
As of Feb 8, 2:08 PM ET ·
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +69.7% upside
Low Target $16.75
Average Target $20.50
High Target $26.76
Current Price $12.08
Current
$12.08
Target
$20.50
$16.75 $20.50 avg $26.76
Scenario Analysis
Bear Case
$16.75
38.7%
Low target
Base Case
$20.50
+69.7%
Avg target
Bull Case
$26.76
+121.5%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$29.58
-59.2% from high
52-Week Low
$12.94
+-6.6% from low
Target vs 52W High
$20.50
-30.7% vs high
Next Earnings Report
Feb 25, 2026 · Before Market Open
9d
until earnings
EPS Est: $-0.07
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +11.4%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -55.0%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.6%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -76.3%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +78.8%